India offers great market in oncology for UK

Mr Mowles has 30 years’ experience working in the healthcare and life sciences sector, during which he has undertaken a wide range of roles in industry and research.

mr-jon-mowles-sector-specialist-life-sciences-investment-organization-ukti

Mr Jon Mowles, Sector Specialist, Life Sciences Investment Organization, UK Trade & Investment (Photo Courtesy: www.tecnologia.publicacionmedica.com)

He became the general manager and UK director at BioChem Pharma prior to working as an independent management consultant for Swiss, French, US and Japanese biotech companies.

Later, he co-founded two UK-based biotechnology companies. He currently works for UK Trade and Investment (UKTI) as a Life Sciences Sector Specialist.

Q: Can you share insights into the work happening in the area of oncology?

Mr Jon Mowles: Government sponsored organizations encourage the uptake of clinical trials. Indian companies want to come to the UK and collaborate with these organizations.

Also, now we are witnessing a successful track record of recruiting patients for clinical trials. We have more patients now in the area of oncology clinical trials in the UK than anywhere else in Europe.

Q: About a million new cancer cases are reported in India every year. How can the UK oncology companies leverage this and create mutual benefits to both India and the UK?

 

Previous 1 3 4 5 6 Next

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

GST

GST: Boon or Bane for Healthcare?

Send this article by email

X